SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-142333
Filing Date
2019-05-09
Accepted
2019-05-09 08:40:05
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d730487d10q.htm 10-Q 600700
2 EX-31.1 d730487dex311.htm EX-31.1 11559
3 EX-31.2 d730487dex312.htm EX-31.2 11594
4 EX-32.1 d730487dex321.htm EX-32.1 6869
  Complete submission text file 0001193125-19-142333.txt   3984415

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20190331.xml EX-101.INS 945309
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20190331.xsd EX-101.SCH 37916
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20190331_cal.xml EX-101.CAL 29050
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20190331_def.xml EX-101.DEF 263853
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20190331_lab.xml EX-101.LAB 245539
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20190331_pre.xml EX-101.PRE 285077
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 19808941
SIC: 2834 Pharmaceutical Preparations